Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study.

Biomedicines · 2025 · PMC12024904 · PMID 40299478

Europe PMC DOI

hedged sentences

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantp = 0.08so close (0.05 < p ≤ 0.1)

Pre-OCS demonstrated a borderline significant association with the outcome (OR = 0.876, 95% CI: 0.756–1.01, p = 0.08).

also in 11,409 other papers

borderline significanceno p-value reported

Despite its borderline significance, the model’s predictive performance improvement supported its inclusion.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.